Home LiteratureArticle Details
PMID: 4387222 Published · ppublish English Journal Article

Cephalexin and cephaloglycin activity in vitro and absorption and urinary excretion of single oral doses in normal young adults.

Applied microbiology ·Vol. 16 ·No. 11 ·1968-11-00 ·Pages 1684-94

Braun P, Tillotson JR, Wilcox C, Finland M

Abstract

A large number of recently isolated bacterial pathogens were tested for susceptibility to cephalexin and cephaloglycin by the replica inoculating method. Strains of group A hemolytic streptococci, viridans (alpha and gamma) streptococci, pneumococci, gonococci, meningococci, and penicillin G-sensitive Staphylococcus aureus were all moderately to highly susceptible to both of these cephalosporin analogues, nearly all of the strains being two to eight (median four) times more susceptible to cephaloglycin than to cephalexin. The penicillin G-resistant, penicillinase-producing strains of S. aureus varied in their susceptibility; many were moderately resistant to both analogues, particularly to cephalexin. Strains of enterococci, Haemophilus influenzae, and most of the common gram-negative bacilli were moderately to highly resistant. Reducing the size of the inoculum had variable effects on inhibition by these drugs, depending on the species or strain. The activity of cephalexin was very little affected by pH of the medium within the clinical range or by incubation at 37 C in broth for up to 24 hr. In contrast, cephaloglycin in broth deteriorated rapidly at 37 C, and its activity was markedly reduced in alkaline medium. Both cephalexin and cephaloglycin were rapidly absorbed and excreted into the urine after single oral doses of 500 mg. Much higher levels were achieved and sustained with the former. Absorption of both analogues was delayed when taken with food, and the levels in the serum were significantly higher and better sustained when probenecid was also given. Very high concentrations of cephalexin were excreted into the urine during the first 4 hr, and the levels were still high in the 4- to 8-hr collection. The concentrations of cephaloglycin in the urine at these times were much lower. An average of 80 to 93% of the dose of cephalexin and 25 to 30% of the cephaloglycin were accounted for as active drug in the urine collected in 8 hr. Both analogues were well tolerated.

MeSH Terms
Adult Cephalosporins/administration & dosage,blood,pharmacology,urine Enterobacteriaceae/drug effects Escherichia coli/drug effects Haemophilus influenzae/drug effects Humans In Vitro Techniques Klebsiella/drug effects Neisseria gonorrhoeae/drug effects Neisseria meningitidis/drug effects Penicillin Resistance Proteus/drug effects Pseudomonas aeruginosa/drug effects Serratia marcescens/drug effects Staphylococcus/drug effects Streptococcus/drug effects Streptococcus pneumoniae/drug effects
Chemicals
Cephalosporins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Braun P
Tillotson J R
Wilcox C
Finland M
References (14)
14 references, click to expand
  1. Levels of penicillin in serum of newborn infants.
    Am J Dis Child. 1966 Mar;111(3):267-71 PMID: 5904465
  2. Cephaloridine activity in vitro and absorption and urinary excretion in normal young men.
    Am J Med Sci. 1966 Apr;251(4):433-48 PMID: 5325753
  3. Cephalexin, a new orally absorbed cephalosporin antibiotic.
    Appl Microbiol. 1967 Jul;15(4):765-9 PMID: 4383049
  4. Resistance and cross-resistance of Staphylococcus aureus, Escherichia coli, and Aerobacter species to cephalosporins and semisynthetic penicillins.
    Antimicrob Agents Chemother (Bethesda). 1966;6:75-81 PMID: 4860775
  5. Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin.
    Antimicrob Agents Chemother (Bethesda). 1966;6:82-7 PMID: 5982343
  6. Clinical evaluation of cephaloridine.
    Arch Intern Med. 1968 Jan;121(1):24-38 PMID: 5635071
  7. Comparative studies of ampicillin, cephalothin and a new cephalosporin derivative, cephaloglycin.
    Am J Med Sci. 1968 Mar;255:196-201 PMID: 4868527
  8. Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections.
    Yale J Biol Med. 1968 Feb;40(4):284-95 PMID: 4870320
  9. In vitro antimicrobial activity and human pharmacology of cephaloglycin.
    Appl Microbiol. 1968 Jul;16(7):1006-10 PMID: 4385749
  10. Clinical experience with cephaloglycin.
    Antimicrob Agents Chemother (Bethesda). 1967;7:624-9 PMID: 5596200
  11. Antimicrobial activity and pharmacological behavior of cephaloglycine.
    Antimicrob Agents Chemother (Bethesda). 1967;7:630-5 PMID: 5596201
  12. Susceptibility of staphylococci to new antimicrobial agents.
    Antimicrob Agents Chemother (Bethesda). 1967;7:697-704 PMID: 5596209
  13. CEPHALOTHIN: ACTIVITY IN VITRO, ABSORPTION AND EXCRETION IN NORMAL SUBJECTS AND CLINICAL OBSERVATIONS IN 40 PATIENTS.
    Am J Med Sci. 1964 Dec;248:640-56 PMID: 14251901
  14. IN VITRO AND IN VIVO LABORATORY EVALUATION OF CEPHALOGLYCIN AND CEPHALORIDINE.
    Appl Microbiol. 1965 Mar;13:248-53 PMID: 14325888
Article Info
Journal
Applied microbiology
Abbr.
Appl Microbiol
ISSN
0003-6919
Published
1968-11-00
Pages
1684-94
Language
English
Region
United States
NLM ID
7605802
PMCID
PMC547740
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]